Atrium Therapeutics Inc (RNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 276,423 | 301,273 | 321,462 | 341,142 | 352,446 |
| Marketable Securities | 3,035 | 6,641 | 6,679 | N/A | N/A |
| Other current assets | 7,851 | 4,036 | 3,537 | 3,155 | 1,371 |
| TOTAL | $287,309 | $311,950 | $331,678 | $344,297 | $353,817 |
| Non-Current Assets | |||||
| PPE Net | 4,413 | 3,898 | 3,447 | 3,196 | 2,571 |
| TOTAL | $4,413 | $3,898 | $3,447 | $3,196 | $2,571 |
| Total Assets | $290,523 | $314,752 | $333,898 | $346,133 | $355,355 |
| Liabilities | |||||
| Current Liabilities | |||||
| TOTAL | $16,338 | $17,514 | $14,587 | $13,680 | $11,620 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $26,043 | $28,636 | $27,675 | $25,969 | $25,059 |
| Shareholders' Equity | |||||
| Retained earnings | -116,737 | -90,384 | -66,540 | -50,265 | -38,826 |
| Other shareholders' equity | 381,217 | 376,500 | 372,763 | 370,429 | 369,122 |
| TOTAL | $264,480 | $286,116 | $306,223 | $320,164 | $330,296 |
| Total Liabilities And Equity | $290,523 | $314,752 | $333,898 | $346,133 | $355,355 |